A laboratory result answers an important question: can the technology work? A first customer asks several more. Can it operate on our site? Who will maintain it? What will it cost? What happens if it fails?
Deep tech startups in Asia Pacific have to connect those questions while the product is still developing. Here, deep tech means businesses whose core advantage depends on substantial scientific or engineering development, including areas such as advanced materials, energy systems and medical technology. Commercialisation means turning that capability into something a customer can adopt and pay for.
The useful starting point is to identify the next piece of evidence a buyer needs. That could be a field test, a viable production process or a clear route to implementation. Funding then has a specific job: to help produce that evidence.
What APAC commercialisation programmes reveal
Three national approaches offer a useful comparison. Enterprise Singapore describes Startup SG Tech as early-stage support for proprietary technology, including proof of concept and proof of value. Japan's NEDO deep-tech support programmes organise support across phases of development and commercialisation. In Australia, CSIRO's ON Accelerate works with research teams on market validation, business models and capital raising.
These programmes are not interchangeable, and their eligibility rules differ. Taken together, however, their design supports an editorial conclusion: technical development and commercial preparation need to advance together. A founder should be able to explain what each new round of work will establish about both.
Programme descriptions were checked on 24 September 2026. ON Accelerate and RISE listed applications as closed. The comparison below explains programme purposes; it is not an invitation to apply or an assurance of eligibility. Programme and route comparison
- Singapore — Startup SG Tech: Proof of concept and proof of value for innovative proprietary technology. Founder question: Which technical or commercial uncertainty will this project resolve?
- Japan — NEDO DTSU / GX: Staged R&D and commercialisation support, including demonstration for mass production. Founder question: What evidence supports the next stage of development?
- Australia — ON Accelerate: Research commercialisation, market validation and business development. Founder question: Who needs this research to become a usable product?
- Australia–India — RISE Accelerator: Cross-border development for more mature technology ventures. Founder question: Can the product be adapted and validated in the other market?
Choose the first customer before chasing the largest market
A large addressable market can attract attention in a pitch deck. It is less helpful when a small engineering team must decide where to run its next test. At that stage, access to a suitable site and a committed user may matter more than the size of the industry.
Consider an illustrative startup developing an industrial sensor. It could pursue factories in several countries at once. A more manageable first step would be to identify a facility with a costly, well-understood problem, a manager willing to share operating data, and a maintenance team able to support a trial. That site would provide conditions under which the product could be assessed.
The founder needs to understand why the facility would act now. An existing replacement cycle, a recurring quality problem or an expensive inspection process could create an opening. General interest in innovation is harder to convert into a timetable.
This choice also shapes the product. A customer may value easy installation more than a small improvement in laboratory performance. Discovering that early can prevent months of development aimed at the wrong specification.
Keep funding milestones separate from customer milestones
CSIRO's June 2026 update on ON Accelerate 10 reported more than A$25.8 million in combined grant funding and capital investment across the cohort. That total represents financing, not customer revenue. It also does not show that every participating venture had reached the same commercial stage.
The examples in the release make that distinction concrete. Air2Energy was preparing a pilot retrofit on gas boilers in Sydney after laboratory trials. CareWindow, a digital care venture, had secured sales under a revised pricing model, including a provider that purchased multiple units and committed to recurring revenue. CSIRO reported these milestones; they are not independently audited results from Global Apex Tech.
For a founder, the lesson is to describe progress in terms a reader can verify. A planned trial, a completed trial, a purchase order and recurring revenue are different events. Combining them under a single label such as 'traction' makes it harder to judge what the business still needs to prove.
Maintain separate records for technical results, financing and customer commitments. The relationship between them is what matters. A grant might fund a test that enables procurement; an investment might fund production capacity after a buyer has committed. Each should have a reason to arrive when it does.
Build the trial around a real operating constraint
The most useful field trial gives the customer a decision it could not make before. Agree which uncertainty is being tested and how the result will be assessed. For a new material, that may involve performance under the customer's processing conditions. For equipment, installation time, uptime and servicing may be central.
Choose a comparison that the buyer recognises. Measuring a prototype against an idealised laboratory benchmark may say little about replacing an existing process. Record the operating conditions and the person responsible for reviewing the result.
The trial should also reveal the demands placed on the startup. If every installation requires weeks of founder involvement, that is part of the business model. Identify what can be standardised, what a partner could provide and what will remain a specialist service.
Our view is that a smaller trial with clear operating evidence can be more valuable than a prestigious partnership announcement with no agreed next step. A partnership earns its place in the commercial plan when it supplies something tangible: a test site, equipment access, engineering support or a route to purchasing.
BuiMatch finance to the uncertainty being removed
NEDO's programme structure is instructive here. Its published phases move from prototypes and initial customer problems towards sustainable revenue and demonstration for mass production. The agency also uses stage-gate reviews. The wider lesson for founders is to make progression explicit: what must be demonstrated before the company spends on the next stage? For an illustrative hardware venture, early funding could establish technical feasibility. A later project might test reliability in a customer environment. Production investment would address a different question: can the company deliver consistently at a workable cost? Those activities have different timelines and dependencies.
Build the cash plan around the work, including installation, evaluation time and the gap before an invoice is paid. A technically successful project can still put pressure on cash if the team must support several trials before any customer commits to an order.
Programme selection should follow that plan. Check permitted costs, required partners, reporting obligations and the timing of payment with the provider. An attractive funding headline is insufficient if the supported activity does not resolve the startup's next commercial constraint.
Treat international expansion as another validation step
The India Australia RISE Accelerator, delivered by CSIRO with Atal Innovation Mission, NITI Aayog, provides a useful example of support aimed at more mature technology. Its published scope includes connections with customers and partners, and adapting and validating technology for the other market. Individual rounds have their own conditions.
That purpose suggests a sensible order for expansion. First establish what the product needs to operate. Then investigate whether the new market can supply those conditions and support an economic sale. A solution proven at one site may need different servicing, components or local partners elsewhere.
Before selecting a country, identify the customer group, the operating problem and the partner capability required. Ask whether the proposed market gives the company access to a better test environment, a committed buyer or a practical production route. A larger population alone does not answer those questions.
Global Apex Tech's guide to Singapore's startup ecosystem provides wider context on one regional hub. Founders comparing hubs should still make their own decision around the capabilities their product needs next.
What belongs in the first customer file
- Before asking a customer to progress from evaluation to purchase, assemble a concise record covering the following:
- The operating problem, current alternative and person responsible for the decision.
- Test results under stated conditions, including limitations and unresolved failures.
- Installation requirements, maintenance responsibilities and an achievable delivery schedule.
- The basis for pricing and the customer's expected benefit at the proposed operating scale.
- The remaining approval steps and the commitment being requested from the buyer.
This is an editorial checklist, not a programme requirement. Its purpose is to expose missing information while the team still has time to address it.
APAC's research institutions and support programmes can help startups reach the right people and carry out difficult development work. The founder's responsibility is to connect that support to adoption. A first customer arrives when the evidence is sufficient for someone to commit resources to using the product.
Questions founders ask
What is the difference between proof of concept and commercialisation?
Proof of concept establishes whether a technical idea is feasible. Commercialisation also requires a usable offering, a viable delivery model and a customer willing to adopt it.
Programme definitions can differ, so founders should read the relevant provider's criteria. Can an accelerator replace customer validation?
An accelerator can provide expertise, introductions and structured support. The company still needs direct evidence of customer need, operating performance and willingness to pay. Selection into a programme does not establish those results.
Subscribe to The APAC Briefing for more analysis of the companies and institutions turning technology into commercial use.
Published by the Global Apex Tech Editorial Desk. Partner involvement, when applicable, is disclosed above the headline. For editorial questions or source material, contact editor@globalapextech.org.
